Market Tracker

10/20 6:19am ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

140.46
Delayed Data
As of Oct 19
 +0.22 / +0.16%
Today’s Change
96.18
Today|||52-Week Range
149.34
+14.80%
Year-to-Date

Today’s Trading

Previous close140.24
Today’s open140.04
Day’s range139.01 - 141.29
Volume1,436,254
Average volume (3 months)1,908,662
Market cap$31.3B
Dividend yield--
Data as of 10/19/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+20.84%
Earnings growth (next 5 years)+20.62%
Revenue growth (last year)+21.11%
P/E ratio60.8
Price/Sales9.22
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.02+0.03%
BAXBaxter International...-0.37-0.58%
INCYIncyte Corp-0.87-0.76%
VRTXVertex Pharmaceutica...-0.16-0.10%
Data as of 10/19/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.32
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts